Company intelligence / Profile preview

Eurofins Selcia

Ongar, England, United Kingdomeurofins.com ↗

Ownership: Private
Employees: ~62
Development stage: Other

Overview

Eurofins Selcia provides integrated drug discovery and radiolabelling services to pharmaceutical and biotechnology companies worldwide. It does not have its own clinical results or proprietary drugs but supports client programs at all stages.

Modalities: Small moleculeRadiolabelled compound (14C, stable isotopes)Peptides (focus on peptidyl-prolyl isomerase inhibitors)
Industry: Drug Discovery Services

Partnerships

Works with global pharma and biotech companies as clients/collaborators; specific partnerships typically confidential or project-based

Beyond the preview

Go deeper on Eurofins Selcia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eurofins Selcia.

Explore the full profile